首页> 外文期刊>Clinical Endocrinology >Arginine vasopressin-dependent and AVP-independent mechanisms of renal fluid absorption during thirsting despite glucocorticoid-mediated vasopressin suppression
【24h】

Arginine vasopressin-dependent and AVP-independent mechanisms of renal fluid absorption during thirsting despite glucocorticoid-mediated vasopressin suppression

机译:尽管糖皮质激素介导的加压素抑制作用,但在渴求过程中精氨酸加压素依赖性和AVP依赖性肾液吸收机制

获取原文
获取原文并翻译 | 示例
           

摘要

Objective Glucocorticoids seem to modify the release and effects of plasma arginine vasopressin (pAVP). However, underlying processes are not well understood. This study aimed to evaluate the mechanism of the modulating effects of glucocorticoids on pAVP and renal water reabsorption. Design Fluid deprivation tests were performed without (d0) and after one (d1) and five days (d5) of oral prednisolone (Pred) pretreatment in a dosage relevant to drug therapy (30 mg/day). Patients Twelve healthy male volunteers participated in this trial. Measurements Plasma and urinary osmolality, pAVP, renin, aldosterone, plasma atrial natriuretic peptide (ANP) as well as urinary secretion of aquaporin-2 (AQP2) and prostaglandin E2 (PGE2) were analysed. Results An appropriate rise in pAVP was observable during thirsting (P 0??001), which was absent after Pred pretreatment. However, the plasma and urinary osmolality after Pred treatment did not differ when compared with the basal thirsting test. Unchanged urinary AQP2 excretion suggests AVP-independent mechanisms of renal fluid reabsorption. Plasma renin concentration as well as ANP was substantially increased after Pred intake at d1 and d5 (both P 0??05), which may mediate such AVP-independent mechanisms. Urinary PGE2 secretion was not influenced by Pred pretreatment, making a PGE2-mediated effect on renal AQP2 translocation and water permeability unlikely. Increased efficacy of exogenous desmopressin at d1 and d5 indicates also a relative increase in AVP sensitivity of the tubular cells after Pred intake. Conclusions The here presented data are compatible with an increased AVP sensitivity and a partially AVP-independent regulation of AQP2 translocation and renal fluid reabsorption during glucocorticoid treatment. ? 2012 Blackwell Publishing Ltd.
机译:目的糖皮质激素似乎会改变血浆精氨酸加压素(pAVP)的释放和作用。但是,底层的过程还没有被很好地理解。本研究旨在评估糖皮质激素对pAVP和肾水重吸收的调节作用机制。设计在没有口服药物泼尼松龙(Pred)的情况下(d0)以及在与药物治疗有关的剂量(30 mg /天)进行口服泼尼松龙(Pred)预处理(d1)和五天(d5)之后进行液体剥夺测试。患者12名健康的男性志愿者参加了该试验。测量分析血浆和尿渗透压,pAVP,肾素,醛固酮,血浆心钠素(ANP)以及水通道蛋白2(AQP2)和前列腺素E2(PGE2)的尿液分泌。结果口渴期间pAVP适当升高(P <0≤001),这在Pred预处理后没有出现。但是,与基础口渴试验相比,Pred治疗后的血浆和尿渗透压没有变化。尿AQP2排泄未改变提示肾液重吸收不依赖AVP的机制。在d1和d5摄入Pred后,血浆肾素浓度和ANP显着增加(均为P <0→05),这可能介导了这种AVP依赖性机制。尿PGE2的分泌不受Pred预处理的影响,因此PGE2介导的对肾脏AQP2易位和透水性的作用不太可能。外源去氨加压素在d1和d5的功效增强也表明在摄入Pred后肾小管细胞的AVP敏感性相对增加。结论本文提供的数据与糖皮质激素治疗期间AVP敏感性增加和AQP2易位和肾液重吸收的部分不依赖AVP的调节兼容。 ? 2012布莱克威尔出版有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号